JP2000511110A - 超臨界流体を使用したマイクロカプセル化方法 - Google Patents
超臨界流体を使用したマイクロカプセル化方法Info
- Publication number
- JP2000511110A JP2000511110A JP10517581A JP51758198A JP2000511110A JP 2000511110 A JP2000511110 A JP 2000511110A JP 10517581 A JP10517581 A JP 10517581A JP 51758198 A JP51758198 A JP 51758198A JP 2000511110 A JP2000511110 A JP 2000511110A
- Authority
- JP
- Japan
- Prior art keywords
- polymer
- core material
- temperature
- supercritical
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 246
- 239000012530 fluid Substances 0.000 title claims abstract description 179
- 229920000642 polymer Polymers 0.000 claims abstract description 306
- 239000011162 core material Substances 0.000 claims abstract description 242
- 239000000463 material Substances 0.000 claims abstract description 68
- 239000003094 microcapsule Substances 0.000 claims abstract description 63
- 239000000203 mixture Substances 0.000 claims abstract description 36
- 238000002156 mixing Methods 0.000 claims abstract description 28
- 230000008961 swelling Effects 0.000 claims abstract description 21
- 229960005486 vaccine Drugs 0.000 claims description 91
- 241000700605 Viruses Species 0.000 claims description 47
- 241000702626 Infectious bursal disease virus Species 0.000 claims description 32
- 230000002411 adverse Effects 0.000 claims description 27
- 229920001610 polycaprolactone Polymers 0.000 claims description 27
- 239000004632 polycaprolactone Substances 0.000 claims description 25
- 229920001577 copolymer Polymers 0.000 claims description 24
- 239000002245 particle Substances 0.000 claims description 24
- 239000003960 organic solvent Substances 0.000 claims description 22
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 19
- 239000000975 dye Substances 0.000 claims description 18
- SJZRECIVHVDYJC-UHFFFAOYSA-N 4-hydroxybutyric acid Chemical compound OCCCC(O)=O SJZRECIVHVDYJC-UHFFFAOYSA-N 0.000 claims description 14
- 239000000853 adhesive Substances 0.000 claims description 14
- 230000001070 adhesive effect Effects 0.000 claims description 14
- 239000003242 anti bacterial agent Substances 0.000 claims description 14
- 239000002781 deodorant agent Substances 0.000 claims description 14
- 235000015872 dietary supplement Nutrition 0.000 claims description 14
- 239000003337 fertilizer Substances 0.000 claims description 14
- 239000003205 fragrance Substances 0.000 claims description 14
- 239000000417 fungicide Substances 0.000 claims description 14
- 239000004009 herbicide Substances 0.000 claims description 14
- 239000000976 ink Substances 0.000 claims description 14
- 230000002503 metabolic effect Effects 0.000 claims description 14
- 239000003607 modifier Substances 0.000 claims description 14
- 239000000575 pesticide Substances 0.000 claims description 14
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Natural products OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 13
- 230000003444 anaesthetic effect Effects 0.000 claims description 12
- 230000003115 biocidal effect Effects 0.000 claims description 12
- 230000000855 fungicidal effect Effects 0.000 claims description 12
- 230000002363 herbicidal effect Effects 0.000 claims description 12
- 230000001225 therapeutic effect Effects 0.000 claims description 12
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 11
- 229920000954 Polyglycolide Polymers 0.000 claims description 10
- 229920003232 aliphatic polyester Polymers 0.000 claims description 10
- JRHWHSJDIILJAT-UHFFFAOYSA-N 2-hydroxypentanoic acid Chemical compound CCCC(O)C(O)=O JRHWHSJDIILJAT-UHFFFAOYSA-N 0.000 claims description 8
- 229920000562 Poly(ethylene adipate) Polymers 0.000 claims description 8
- 239000004310 lactic acid Substances 0.000 claims description 8
- 235000014655 lactic acid Nutrition 0.000 claims description 8
- 210000004779 membrane envelope Anatomy 0.000 claims description 6
- 229920013641 bioerodible polymer Polymers 0.000 claims description 5
- 244000309711 non-enveloped viruses Species 0.000 claims description 5
- 108010008038 Synthetic Vaccines Proteins 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 229940014144 folate Drugs 0.000 claims description 4
- 235000019152 folic acid Nutrition 0.000 claims description 4
- 239000011724 folic acid Substances 0.000 claims description 4
- 229940031551 inactivated vaccine Drugs 0.000 claims description 4
- 229940124551 recombinant vaccine Drugs 0.000 claims description 4
- 229940031626 subunit vaccine Drugs 0.000 claims description 4
- 239000002861 polymer material Substances 0.000 abstract description 14
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 54
- 239000011257 shell material Substances 0.000 description 46
- 238000004965 Hartree-Fock calculation Methods 0.000 description 42
- 239000003814 drug Substances 0.000 description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 30
- 239000002904 solvent Substances 0.000 description 24
- 239000007788 liquid Substances 0.000 description 23
- 210000004027 cell Anatomy 0.000 description 21
- 239000007787 solid Substances 0.000 description 20
- 238000002844 melting Methods 0.000 description 19
- 230000008018 melting Effects 0.000 description 19
- 230000008569 process Effects 0.000 description 19
- 239000000126 substance Substances 0.000 description 19
- 229940124597 therapeutic agent Drugs 0.000 description 18
- 238000007614 solvation Methods 0.000 description 17
- 229940079593 drug Drugs 0.000 description 14
- 238000000576 coating method Methods 0.000 description 13
- 239000011248 coating agent Substances 0.000 description 12
- 239000000843 powder Substances 0.000 description 12
- 239000003795 chemical substances by application Substances 0.000 description 11
- 239000000523 sample Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 8
- 238000004945 emulsification Methods 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- 239000011159 matrix material Substances 0.000 description 8
- 238000012545 processing Methods 0.000 description 8
- 239000002699 waste material Substances 0.000 description 8
- 230000006870 function Effects 0.000 description 7
- 239000008240 homogeneous mixture Substances 0.000 description 7
- 239000011859 microparticle Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 241000287828 Gallus gallus Species 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000013543 active substance Substances 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- 235000013330 chicken meat Nutrition 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 230000009477 glass transition Effects 0.000 description 6
- 229960000448 lactic acid Drugs 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000004005 microsphere Substances 0.000 description 6
- 238000006116 polymerization reaction Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000003068 static effect Effects 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 238000004090 dissolution Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000005538 encapsulation Methods 0.000 description 5
- 239000010419 fine particle Substances 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 230000002458 infectious effect Effects 0.000 description 5
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 5
- 229960004844 lovastatin Drugs 0.000 description 5
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000013270 controlled release Methods 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 230000003628 erosive effect Effects 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 230000000704 physical effect Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 239000008223 sterile water Substances 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 229920001897 terpolymer Polymers 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 230000035899 viability Effects 0.000 description 4
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical class CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- 239000004570 mortar (masonry) Substances 0.000 description 3
- 150000002894 organic compounds Chemical class 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 229920001308 poly(aminoacid) Polymers 0.000 description 3
- 239000004626 polylactic acid Substances 0.000 description 3
- 230000002459 sustained effect Effects 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 description 2
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 235000014676 Phragmites communis Nutrition 0.000 description 2
- 229920002319 Poly(methyl acrylate) Polymers 0.000 description 2
- 229920001710 Polyorthoester Polymers 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N Valeric acid Natural products CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000003570 air Substances 0.000 description 2
- 229920006125 amorphous polymer Polymers 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000002830 appetite depressant Substances 0.000 description 2
- 239000012867 bioactive agent Substances 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000000120 cytopathologic effect Effects 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 238000011978 dissolution method Methods 0.000 description 2
- 239000013583 drug formulation Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000000576 food coloring agent Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000007972 injectable composition Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 230000008774 maternal effect Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 229920001432 poly(L-lactide) Polymers 0.000 description 2
- 239000002745 poly(ortho ester) Substances 0.000 description 2
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 239000004633 polyglycolic acid Substances 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 239000001294 propane Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 239000013557 residual solvent Substances 0.000 description 2
- 238000013341 scale-up Methods 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 238000004781 supercooling Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 description 2
- 229940005605 valeric acid Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000010887 waste solvent Substances 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- 208000027312 Bursal disease Diseases 0.000 description 1
- WJYYDHDGDWVQCF-UHFFFAOYSA-N C(CCC)(=O)O.C(C)(=O)OCCCCCCC Chemical compound C(CCC)(=O)O.C(C)(=O)OCCCCCCC WJYYDHDGDWVQCF-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920006217 cellulose acetate butyrate Polymers 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 125000004773 chlorofluoromethyl group Chemical group [H]C(F)(Cl)* 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000011258 core-shell material Substances 0.000 description 1
- 150000004292 cyclic ethers Chemical class 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000010128 melt processing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000003863 physical function Effects 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000679 solder Inorganic materials 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229910052714 tellurium Inorganic materials 0.000 description 1
- PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical group [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
- Y10T428/2985—Solid-walled microcapsule from synthetic polymer
- Y10T428/2987—Addition polymer from unsaturated monomers only
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2989—Microcapsule with solid core [includes liposome]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/727,154 US5766637A (en) | 1996-10-08 | 1996-10-08 | Microencapsulation process using supercritical fluids |
| US08/727,154 | 1996-10-08 | ||
| PCT/US1997/017509 WO1998015348A1 (en) | 1996-10-08 | 1997-10-01 | Microencapsulation process using supercritical fluids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2000511110A true JP2000511110A (ja) | 2000-08-29 |
Family
ID=24921541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10517581A Pending JP2000511110A (ja) | 1996-10-08 | 1997-10-01 | 超臨界流体を使用したマイクロカプセル化方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5766637A (no) |
| EP (1) | EP0948396A1 (no) |
| JP (1) | JP2000511110A (no) |
| CN (1) | CN1232411A (no) |
| AR (1) | AR008867A1 (no) |
| AU (1) | AU713965B2 (no) |
| BR (1) | BR9711590A (no) |
| CA (1) | CA2267350A1 (no) |
| CO (1) | CO4900026A1 (no) |
| IN (1) | IN183694B (no) |
| NO (1) | NO991571L (no) |
| NZ (1) | NZ334815A (no) |
| PE (1) | PE1499A1 (no) |
| WO (1) | WO1998015348A1 (no) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002506428A (ja) * | 1997-05-10 | 2002-02-26 | ユニヴァーシティー オヴ ノッティングハム | 超臨界流体中で調製した生体機能ポリマー |
| JP2002204942A (ja) * | 2001-01-11 | 2002-07-23 | Mayekawa Mfg Co Ltd | 液状物質の超臨界連続処理方法とその装置及び冷凍サイクル併用の超臨界連続処理システム |
| JP2004175922A (ja) * | 2002-11-27 | 2004-06-24 | Toppan Forms Co Ltd | ヌクレオチド重合体マイクロカプセルインキ |
| JP2005520025A (ja) * | 2002-03-13 | 2005-07-07 | ノッティンガム大学 | 内部的に分散沈殿物を有する高分子複合材料 |
| JP2007500940A (ja) * | 2003-07-29 | 2007-01-18 | 東京エレクトロン株式会社 | 処理チャンバ内のみへの処理化学物質のフローの制御 |
| JP2008512233A (ja) * | 2004-09-09 | 2008-04-24 | ピエール・ファーブル・メディカマン | 粉末の被覆方法 |
| US7736558B2 (en) | 2003-01-07 | 2010-06-15 | Hitachi Maxell, Ltd. | Imprint manufacture method |
| JP2011527328A (ja) * | 2008-07-11 | 2011-10-27 | クリティカル ファーマシューティカルズ リミテッド | 微粒子を調製する方法 |
| JP2021528350A (ja) * | 2018-06-20 | 2021-10-21 | ティッセンクルップ インダストリアル ソリューションズ アクツィエンゲゼルシャフトＴｈｙｓｓｅｎＫｒｕｐｐ Ｉｎｄｕｓｔｒｉａｌ Ｓｏｌｕｔｉｏｎｓ ＡＧ | 尿素含有顆粒をコーティングする方法における有機ポリマー用の溶剤としての超臨界ｃｏ２の使用 |
| WO2022023833A1 (en) | 2020-07-31 | 2022-02-03 | Ricoh Company, Ltd. | Composition, manufacture, and method for producing composition |
Families Citing this family (100)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0706821A1 (en) * | 1994-10-06 | 1996-04-17 | Centre De Microencapsulation | Method of coating particles |
| DE19545257A1 (de) | 1995-11-24 | 1997-06-19 | Schering Ag | Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln |
| FR2753639B1 (fr) * | 1996-09-25 | 1998-12-11 | Procede de preparation de microcapsules de matieres actives enrobees par un polymere et nouvelles microcapsules notamment obtenues selon le procede | |
| US6299937B1 (en) * | 1996-10-28 | 2001-10-09 | Douglas S. Richart | Methods and means for modifying the surfaces of polymeric solids |
| US6060084A (en) * | 1997-08-28 | 2000-05-09 | Cannon Chemical Company | Method for preparing a core material containment system and the core material containment system prepared thereby |
| ATE453460T1 (de) | 1997-10-15 | 2010-01-15 | Univ South Florida | Beschichtung von partikelmaterial mittels superkritischer flüssigkeit |
| WO1999021662A1 (en) * | 1997-10-25 | 1999-05-06 | Richart Douglas S | Modifying the surfaces of polymeric solids |
| US6184270B1 (en) | 1998-09-21 | 2001-02-06 | Eric J. Beckman | Production of power formulations |
| FR2787730B1 (fr) * | 1998-12-29 | 2001-02-09 | Oreal | Nanocapsules a base de poly(alkylene adipate), leur procede de preparation et compositions cosmetiques ou dermatologiques les contenant |
| US6303355B1 (en) | 1999-03-22 | 2001-10-16 | Duke University | Method of culturing, cryopreserving and encapsulating pancreatic islet cells |
| US6365385B1 (en) | 1999-03-22 | 2002-04-02 | Duke University | Methods of culturing and encapsulating pancreatic islet cells |
| AU3957400A (en) * | 1999-04-16 | 2000-11-02 | Novo Nordisk A/S | Dry, mouldable drug formulation |
| US6368620B2 (en) * | 1999-06-11 | 2002-04-09 | Abbott Laboratories | Formulations comprising lipid-regulating agents |
| FR2797398B1 (fr) * | 1999-08-11 | 2002-10-18 | Mainelab | Microparticules pour administration pulmonaire |
| US6397421B1 (en) * | 1999-09-24 | 2002-06-04 | Micell Technologies | Methods and apparatus for conserving vapor and collecting liquid carbon dioxide for carbon dioxide dry cleaning |
| US6314601B1 (en) * | 1999-09-24 | 2001-11-13 | Mcclain James B. | System for the control of a carbon dioxide cleaning apparatus |
| FR2803539B1 (fr) * | 2000-01-07 | 2002-07-12 | Separex Sa | Procede de captage et d'encapsulation de fines particules |
| WO2001080831A2 (en) | 2000-04-27 | 2001-11-01 | Verion Inc. | Zero order release and temperature-controlled microcapsules and process for the preparation thereof |
| FR2809309B1 (fr) * | 2000-05-23 | 2004-06-11 | Mainelab | Microspheres a liberation prolongee pour administration injectable |
| US20020009584A1 (en) * | 2000-06-14 | 2002-01-24 | Boyer Thomas D. | Encapsulation using microcellular foamed materials |
| ATE355813T1 (de) * | 2000-07-14 | 2007-03-15 | Novo Nordisk As | Verfahren zum formen einer pharmazeutischen zusammensetzung in einem verpackungsmaterial |
| US6967028B2 (en) | 2000-07-31 | 2005-11-22 | Mainelab | Prolonged release microspheres for injectable administration |
| DE10041003A1 (de) * | 2000-08-22 | 2002-03-28 | Sueddeutsche Kalkstickstoff | Verfahren zum Imprägnieren einer Trägermatrix mit festen und/oder flüssigen Verbindungen mit Hilfe komprimierter Gase und so imprägnierte Stoffe |
| US6723363B2 (en) * | 2000-08-29 | 2004-04-20 | The Penn State Research Foundation | Coating foods and pharmaceuticals with an edible polymer using carbon dioxide |
| US6521258B1 (en) * | 2000-09-08 | 2003-02-18 | Ferro Corporation | Polymer matrices prepared by supercritical fluid processing techniques |
| US20030215572A1 (en) * | 2000-10-10 | 2003-11-20 | Naoki Nojiri | Process for preparing composite particles |
| ATE416784T1 (de) | 2000-12-01 | 2008-12-15 | Takeda Pharmaceutical | Verfahren zur herstellung einer zubereitung mit einer bioaktiven substanz |
| ATE375145T1 (de) | 2000-12-21 | 2007-10-15 | Alrise Biosystems Gmbh | Induziertes phasenübergangs verfahren zur herstellung von hydrophile wirkstoffe enthaltende mikropartikeln |
| US20020130430A1 (en) * | 2000-12-29 | 2002-09-19 | Castor Trevor Percival | Methods for making polymer microspheres/nanospheres and encapsulating therapeutic proteins and other products |
| US7708915B2 (en) * | 2004-05-06 | 2010-05-04 | Castor Trevor P | Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein |
| ES2305250T3 (es) * | 2001-05-30 | 2008-11-01 | Csir | Procedimiento de encapsulacion de una sustancia activa. |
| US20030044514A1 (en) * | 2001-06-13 | 2003-03-06 | Richard Robert E. | Using supercritical fluids to infuse therapeutic on a medical device |
| FR2830760B1 (fr) | 2001-10-12 | 2004-06-04 | Pf Medicament | Procede de preparation d'un compose d'interaction de substances actives avec un support poreux par fluide supercritique |
| GB0126716D0 (en) * | 2001-11-07 | 2002-01-02 | Advanced Phytonics Ltd | Method for the production of particles |
| US20070196415A1 (en) * | 2002-11-14 | 2007-08-23 | Guohua Chen | Depot compositions with multiple drug release rate controls and uses thereof |
| EP1446100B1 (en) * | 2001-11-14 | 2011-05-04 | Durect Corporation | Injectable depot compositions and uses thereof |
| NZ533436A (en) * | 2001-11-14 | 2007-10-26 | Alza Corp | Catheter injectable depot compositons and uses thereof |
| EP1490175A2 (de) * | 2001-12-10 | 2004-12-29 | Sartorius Ag | Mikroarray-vorrichtung |
| US8454997B2 (en) | 2001-12-18 | 2013-06-04 | Novo Nordisk A/S | Solid dose micro implant |
| US6974592B2 (en) * | 2002-04-11 | 2005-12-13 | Ocean Nutrition Canada Limited | Encapsulated agglomeration of microcapsules and method for the preparation thereof |
| WO2003088951A1 (en) * | 2002-04-15 | 2003-10-30 | Eiffel Technologies Limited | Formulation of fine particles using liquefied or dense gases |
| US20040001889A1 (en) * | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
| DK1539101T3 (da) * | 2002-07-31 | 2009-04-27 | Alza Corp | Injicerbare, multi-modale polymere depotsammens tninger og anvendelser deraf |
| KR20050038008A (ko) * | 2002-07-31 | 2005-04-25 | 알자 코포레이션 | 주사용 저장형 조성물 및 이의 용도 |
| US6966990B2 (en) | 2002-10-11 | 2005-11-22 | Ferro Corporation | Composite particles and method for preparing |
| KR20110112481A (ko) * | 2002-11-04 | 2011-10-12 | 오션 뉴트리션 캐나다 리미티드 | 다중 쉘을 갖는 마이크로캡슐 및 이의 제조 방법 |
| US20040091617A1 (en) * | 2002-11-11 | 2004-05-13 | Crompton Corporation | Method and device for applying a thick reactive coating on a body rotating about an axis |
| WO2004044281A2 (en) * | 2002-11-12 | 2004-05-27 | The Regents Of The University Of California | Nano-porous fibers and protein membranes |
| US6780249B2 (en) * | 2002-12-06 | 2004-08-24 | Eastman Kodak Company | System for producing patterned deposition from compressed fluid in a partially opened deposition chamber |
| US7217749B2 (en) * | 2003-01-20 | 2007-05-15 | Northern Technologies International Corporation | Process for infusing an alkali metal nitrite into a synthetic resinous material |
| US7217750B2 (en) * | 2003-01-20 | 2007-05-15 | Northern Technologies International Corporation | Process for incorporating one or more materials into a polymer composition and products produced thereby |
| US6931888B2 (en) * | 2003-02-07 | 2005-08-23 | Ferro Corporation | Lyophilization method and apparatus for producing particles |
| US7083748B2 (en) * | 2003-02-07 | 2006-08-01 | Ferro Corporation | Method and apparatus for continuous particle production using supercritical fluid |
| US7449136B2 (en) * | 2003-02-21 | 2008-11-11 | Ferro Pfanstiehl Laboratories, Inc. | Method and apparatus for producing composite particles using supercritical fluid as plasticizing and extracting agent |
| WO2005025728A2 (en) | 2003-02-24 | 2005-03-24 | Ferro Corporation | Method and apparatus for enhanced size reduction of particles |
| WO2004091571A2 (en) * | 2003-04-08 | 2004-10-28 | New Jersey Institute Of Technology (Njit) | Polymer coating/encapsulation of nanoparticles using a supercritical antisolvent process |
| KR20060006051A (ko) * | 2003-04-23 | 2006-01-18 | 세키스이가가쿠 고교가부시키가이샤 | 수지 미립자의 제조 방법 및 수지 미립자 |
| FR2854079B1 (fr) | 2003-04-25 | 2007-11-30 | Pf Medicament | Procede de preparation de complexes moleculaires |
| US20060008531A1 (en) * | 2003-05-08 | 2006-01-12 | Ferro Corporation | Method for producing solid-lipid composite drug particles |
| WO2005022603A2 (en) * | 2003-09-02 | 2005-03-10 | Integral Technologies, Inc. | Low cost conductive containers manufactured from conductive loaded resin-based materials |
| US8211593B2 (en) * | 2003-09-08 | 2012-07-03 | Intematix Corporation | Low platinum fuel cells, catalysts, and method for preparing the same |
| US8012210B2 (en) * | 2004-01-16 | 2011-09-06 | Warsaw Orthopedic, Inc. | Implant frames for use with settable materials and related methods of use |
| US20050161843A1 (en) * | 2004-01-23 | 2005-07-28 | Yongcai Wang | Process of producing microcapsules and product thereof |
| US20050202373A1 (en) * | 2004-03-13 | 2005-09-15 | Penny Peng | Novel surgical blade for finishing composite fillings on the mesial surface of molars and premolars and method of use |
| JP4660143B2 (ja) * | 2004-08-27 | 2011-03-30 | 富士フイルム株式会社 | 有機電界発光素子及びその製造方法 |
| US20060142234A1 (en) * | 2004-12-23 | 2006-06-29 | Guohua Chen | Injectable non-aqueous suspension |
| US8034450B2 (en) * | 2005-01-21 | 2011-10-11 | Ocean Nutrition Canada Limited | Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof |
| US6969530B1 (en) | 2005-01-21 | 2005-11-29 | Ocean Nutrition Canada Ltd. | Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof |
| EP1846355B1 (en) * | 2005-01-27 | 2009-12-16 | Ocean Nutrition Canada Limited | Fatty acid-benzenediol derivatives and methods of making and using thereof |
| WO2006109194A2 (en) * | 2005-01-27 | 2006-10-19 | Ocean Nutrition Canada Ltd. | Chromium-fatty acid compounds and methods of making and using thereof |
| US9968120B2 (en) * | 2006-05-17 | 2018-05-15 | Dsm Nutritional Products Ag | Homogenized formulations containing microcapsules and methods of making and using thereof |
| EP1757361A1 (en) * | 2005-08-23 | 2007-02-28 | Feyecon Development & Implementation B.V. | Process for the preparation of encapsulates through precipitation |
| WO2007084609A2 (en) * | 2006-01-19 | 2007-07-26 | Osteotech, Inc. | Porous osteoimplant |
| EP1976460A4 (en) * | 2006-01-19 | 2012-06-20 | Warsaw Orthopedic Inc | INJECTABLE AND FORMABLE BONE REPLACEMENT MATERIALS |
| CN100351010C (zh) * | 2006-03-06 | 2007-11-28 | 大连理工大学 | 超临界撞击流微粒包覆方法 |
| MX292905B (es) * | 2006-04-07 | 2011-12-01 | Ocean Nutrition Canada Ltd | Emulsiones y microcapsulas con sustancias que tienen baja tension interfacial y metodos para fabricar y usar las mismas. |
| FR2900845B1 (fr) * | 2006-05-15 | 2009-03-06 | Commissariat Energie Atomique | Procede et dispositif de synthese de particules organiques ou inorganiques enrobees |
| NZ573327A (en) * | 2006-06-05 | 2012-07-27 | Ocean Nutrition Canada Ltd | Microcapsules with improved shells |
| US7943218B2 (en) * | 2006-08-14 | 2011-05-17 | Frito-Lay North America, Inc. | Environmentally-friendly multi-layer flexible film having barrier properties |
| US20100221560A1 (en) * | 2006-08-14 | 2010-09-02 | Frito-Lay North America, Inc. | Bio-Based In-Line High Barrier Metalized Film and Process for its Production |
| US20090061126A1 (en) * | 2007-08-31 | 2009-03-05 | Anthony Robert Knoerzer | Package and Multi-Layer Flexible Film Having Paper Containing Post Consumer Recycled Fiber |
| US7951436B2 (en) * | 2006-08-14 | 2011-05-31 | Frito-Lay North America, Inc. | Environmentally-friendly multi-layer flexible film having barrier properties |
| AU2008205325B2 (en) | 2007-01-10 | 2013-09-12 | Dsm Nutritional Products Ag | Vegetarian microcapsules |
| DE102008049711A1 (de) * | 2008-09-30 | 2010-04-15 | Siemens Aktiengesellschaft | Lagerungsvorrichtung, Patientenlagerungstisch und medizinisches Gerät |
| US8839145B2 (en) * | 2009-01-21 | 2014-09-16 | Oracle International Corporation | Providing access to contextual actions and information |
| US7985526B2 (en) * | 2009-08-25 | 2011-07-26 | Xerox Corporation | Supercritical fluid microencapsulation of dye into latex for improved emulsion aggregation toner |
| US20110200844A1 (en) * | 2010-02-17 | 2011-08-18 | Frito-Lay North America, Inc. | Composition for facilitating environmental degradation of a film |
| US9040120B2 (en) | 2011-08-05 | 2015-05-26 | Frito-Lay North America, Inc. | Inorganic nanocoating primed organic film |
| US9267011B2 (en) | 2012-03-20 | 2016-02-23 | Frito-Lay North America, Inc. | Composition and method for making a cavitated bio-based film |
| US9162421B2 (en) | 2012-04-25 | 2015-10-20 | Frito-Lay North America, Inc. | Film with compostable heat seal layer |
| CA2872274C (en) | 2012-06-23 | 2016-11-29 | Frito-Lay North America, Inc. | Deposition of ultra-thin inorganic oxide coatings on packaging |
| US9090021B2 (en) | 2012-08-02 | 2015-07-28 | Frito-Lay North America, Inc. | Ultrasonic sealing of packages |
| US9149980B2 (en) | 2012-08-02 | 2015-10-06 | Frito-Lay North America, Inc. | Ultrasonic sealing of packages |
| GB201317756D0 (en) | 2013-10-08 | 2013-11-20 | Critical Pharmaceuticals Ltd | New process |
| US20160303242A1 (en) | 2013-12-09 | 2016-10-20 | Durect Corporation | Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same |
| CN107082704A (zh) * | 2017-05-19 | 2017-08-22 | 陶圣香 | 一种缓释肥的制备方法 |
| CA3167217A1 (en) | 2020-01-13 | 2021-07-22 | Durect Corporation | Sustained release drug delivery systems with reduced impurities and related methods |
| CN112007584A (zh) * | 2020-08-31 | 2020-12-01 | 胡勇刚 | 一种油脂的超临界颗粒制备工艺 |
| CN112515172A (zh) * | 2020-11-30 | 2021-03-19 | 厦门金达威生物科技有限公司 | 一种辅酶q10、vd3和vk2糖玻璃化微胶囊及其制备方法 |
| US11684874B2 (en) | 2020-12-29 | 2023-06-27 | Metal Industries Research & Development Centre | Tangential flow filtration module and tangential flow filtration assembly |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4734451A (en) * | 1983-09-01 | 1988-03-29 | Battelle Memorial Institute | Supercritical fluid molecular spray thin films and fine powders |
| US4582731A (en) * | 1983-09-01 | 1986-04-15 | Battelle Memorial Institute | Supercritical fluid molecular spray film deposition and powder formation |
| US5271881A (en) * | 1987-09-28 | 1993-12-21 | Redding Bruce K | Apparatus and method for making microcapsules |
| DE3744329A1 (de) * | 1987-12-28 | 1989-07-06 | Schwarz Pharma Gmbh | Verfahren zur herstellung einer mindestens einen wirkstoff und einen traeger umfassenden zubereitung |
| DE4041563A1 (de) * | 1990-12-22 | 1992-06-25 | Sanol Arznei Schwarz Gmbh | Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren |
| US6063910A (en) * | 1991-11-14 | 2000-05-16 | The Trustees Of Princeton University | Preparation of protein microparticles by supercritical fluid precipitation |
| US5340614A (en) * | 1993-02-11 | 1994-08-23 | Minnesota Mining And Manufacturing Company | Methods of polymer impregnation |
| EP0706821A1 (en) * | 1994-10-06 | 1996-04-17 | Centre De Microencapsulation | Method of coating particles |
-
1996
- 1996-10-08 US US08/727,154 patent/US5766637A/en not_active Expired - Lifetime
-
1997
- 1997-09-10 IN IN2015MA1997 patent/IN183694B/en unknown
- 1997-10-01 CN CN97198628.2A patent/CN1232411A/zh active Pending
- 1997-10-01 CA CA002267350A patent/CA2267350A1/en not_active Abandoned
- 1997-10-01 NZ NZ334815A patent/NZ334815A/en unknown
- 1997-10-01 JP JP10517581A patent/JP2000511110A/ja active Pending
- 1997-10-01 EP EP97944560A patent/EP0948396A1/en not_active Withdrawn
- 1997-10-01 AR ARP970104520A patent/AR008867A1/es unknown
- 1997-10-01 AU AU46027/97A patent/AU713965B2/en not_active Ceased
- 1997-10-01 WO PCT/US1997/017509 patent/WO1998015348A1/en not_active Application Discontinuation
- 1997-10-01 BR BR9711590A patent/BR9711590A/pt not_active Application Discontinuation
- 1997-10-02 CO CO97057603A patent/CO4900026A1/es unknown
- 1997-10-07 PE PE1997000889A patent/PE1499A1/es not_active Application Discontinuation
-
1999
- 1999-03-30 NO NO991571A patent/NO991571L/no not_active Application Discontinuation
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002506428A (ja) * | 1997-05-10 | 2002-02-26 | ユニヴァーシティー オヴ ノッティングハム | 超臨界流体中で調製した生体機能ポリマー |
| JP4874447B2 (ja) * | 1997-05-10 | 2012-02-15 | ノッティンガム大学 | 超臨界流体中で調製した生体機能ポリマー |
| JP2002204942A (ja) * | 2001-01-11 | 2002-07-23 | Mayekawa Mfg Co Ltd | 液状物質の超臨界連続処理方法とその装置及び冷凍サイクル併用の超臨界連続処理システム |
| JP2005520025A (ja) * | 2002-03-13 | 2005-07-07 | ノッティンガム大学 | 内部的に分散沈殿物を有する高分子複合材料 |
| JP2004175922A (ja) * | 2002-11-27 | 2004-06-24 | Toppan Forms Co Ltd | ヌクレオチド重合体マイクロカプセルインキ |
| US7736558B2 (en) | 2003-01-07 | 2010-06-15 | Hitachi Maxell, Ltd. | Imprint manufacture method |
| JP2007500940A (ja) * | 2003-07-29 | 2007-01-18 | 東京エレクトロン株式会社 | 処理チャンバ内のみへの処理化学物質のフローの制御 |
| JP2008512233A (ja) * | 2004-09-09 | 2008-04-24 | ピエール・ファーブル・メディカマン | 粉末の被覆方法 |
| KR101248347B1 (ko) * | 2004-09-09 | 2013-04-02 | 피에르 파브르 메디카먼트 | 분말의 코팅 방법 |
| JP2011527328A (ja) * | 2008-07-11 | 2011-10-27 | クリティカル ファーマシューティカルズ リミテッド | 微粒子を調製する方法 |
| JP2021528350A (ja) * | 2018-06-20 | 2021-10-21 | ティッセンクルップ インダストリアル ソリューションズ アクツィエンゲゼルシャフトＴｈｙｓｓｅｎＫｒｕｐｐ Ｉｎｄｕｓｔｒｉａｌ Ｓｏｌｕｔｉｏｎｓ ＡＧ | 尿素含有顆粒をコーティングする方法における有機ポリマー用の溶剤としての超臨界ｃｏ２の使用 |
| JP7198554B2 (ja) | 2018-06-20 | 2023-01-04 | ティッセンクルップ インダストリアル ソリューションズ アクツィエンゲゼルシャフト | 尿素含有顆粒をコーティングする方法における有機ポリマー用の溶剤としての超臨界ｃｏ２の使用 |
| WO2022023833A1 (en) | 2020-07-31 | 2022-02-03 | Ricoh Company, Ltd. | Composition, manufacture, and method for producing composition |
Also Published As
| Publication number | Publication date |
|---|---|
| IN183694B (no) | 2000-03-18 |
| CN1232411A (zh) | 1999-10-20 |
| CO4900026A1 (es) | 2000-03-27 |
| BR9711590A (pt) | 1999-08-24 |
| PE1499A1 (es) | 1999-02-11 |
| EP0948396A1 (en) | 1999-10-13 |
| AU713965B2 (en) | 1999-12-16 |
| NZ334815A (en) | 2001-01-26 |
| NO991571D0 (no) | 1999-03-30 |
| US5766637A (en) | 1998-06-16 |
| NO991571L (no) | 1999-06-07 |
| WO1998015348A1 (en) | 1998-04-16 |
| AU4602797A (en) | 1998-05-05 |
| CA2267350A1 (en) | 1998-04-16 |
| AR008867A1 (es) | 2000-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2000511110A (ja) | 超臨界流体を使用したマイクロカプセル化方法 | |
| DK1343480T4 (en) | Induced phase transition method for the preparation of microparticles containing hydrophobic active agents. | |
| US4272398A (en) | Microencapsulation process | |
| FI103183B (fi) | Emulsioon perustuva menetelmä aineen mikrokapseloimiseksi mikrokapselo iduksi tuotteeksi | |
| US4933105A (en) | Process for preparation of microspheres | |
| KR100211435B1 (ko) | 서방성 미소구 제제의 제조방법 | |
| FI64899C (fi) | Foerfarande foer framstaellning av mikrosfaerer bestaoende av en polymer och ett kaernmaterial | |
| EP0768870A1 (en) | Multiple encapsulation of oleophilic substances | |
| Uchida et al. | Preparation and characterization of polylactic acid microspheres containing bovine insulin by aw/o/w emulsion solvent evaporation method | |
| IE58245B1 (en) | Micro-encapsulation of medicaments | |
| US5858531A (en) | Method for preparation of polymer microparticles free of organic solvent traces | |
| CA2397404A1 (en) | Micronized freeze-dried particles | |
| Thakkar et al. | Supercritical fluid technology: a promising approach to enhance the drug solubility | |
| RU2631883C2 (ru) | Способ получения нанокапсул лекарственных препаратов группы пенициллинов в конжаковой камеди | |
| RU2502510C1 (ru) | Способ получения микрокапсул лекарственных препаратов группы цефалоспоринов в конжаковой камеди в четыреххлористом углероде | |
| JP2004035446A (ja) | 微小球体の製造方法およびその製造装置 | |
| US4743583A (en) | Sustained release protein compositions and method for making | |
| RU2619331C2 (ru) | Способ получения нанокапсул умифеновира (Арбидола) в альгинате натрия | |
| JP2004517146A (ja) | 生物活性物質カプセル化生分解性高分子の微粒子および該微粒子を含有する徐放性医薬配合物 | |
| RU2618453C2 (ru) | Способ получения нанокапсул лекарственных препаратов группы пенициллинов в каррагинане | |
| MXPA99003255A (en) | Microencapsulation process using supercritical fluids | |
| RU2609824C1 (ru) | Способ получения нанокапсул лекарственных препаратов группы пенициллинов в альгинате натрия | |
| RU2599007C1 (ru) | Способ получения нанокапсул ципрофлоксацина гидрохлорида в альгинате натрия | |
| JPH07506376A (ja) | マイクロカプセル封入 | |
| RU2691391C1 (ru) | Способ получения нанокапсул метронидазола в каппа-каррагинане |